The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report

Ryan Patrick Fanning, Sara Strout, Nicholas R. Rowan, Clifford R. Weiss, Panagis Galiatsatos

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report'. Together they form a unique fingerprint.

Medicine & Life Sciences